These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38406171)

  • 1. Do Serum Nesfatin-1 Levels have A Predictive Role in Type-2 Diabetes Mellitus and its Microvascular Complications? A Case-Control Study.
    Khalil UA; Mohamed OE; Abdullah AA; Fawzy MS; Rashad NM; Samir GM
    Cureus; 2024 Jan; 16(1):e53007. PubMed ID: 38406171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nesfatin-1 - as a diagnosis regulatory peptide in type 2 diabetes mellitus.
    Kadim BM; Hassan EA
    J Diabetes Metab Disord; 2022 Dec; 21(2):1369-1375. PubMed ID: 36404867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of serum oxLDL/β2-GPI complexes was correlated with diabetic microvascular complications in Type 2 diabetes mellitus patients.
    Xie L; Lin H; Wang C
    J Clin Lab Anal; 2019 Feb; 33(2):e22676. PubMed ID: 30259578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To Study Relationship of Serum hsCRP with Type 2 Diabetes Mellitus, its Vascular Complications and Non-Diabetics - Case Control Study.
    Gupta R; Pamecha H
    J Assoc Physicians India; 2020 Aug; 68(8):25-29. PubMed ID: 32738836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
    Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
    Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between microvascular complications of diabetes mellitus and levels of macro and trace elements.
    Temurer Afşar Z; Ayçiçek B; Tütüncü Y; Çavdar Ü; Sennaroğlu E
    Minerva Endocrinol (Torino); 2023 Sep; 48(3):305-310. PubMed ID: 32623842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasting plasma levels of nesfatin-1 in patients with type 1 and type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans.
    Li QC; Wang HY; Chen X; Guan HZ; Jiang ZY
    Regul Pept; 2010 Jan; 159(1-3):72-7. PubMed ID: 19896982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NESFATIN-1 ACTIVITY IN THE BLOOD SERUM IN PATIENTS WITH CHRONIC HEART FAILURE OF ISCHEMIC ORIGIN AGAINST THE BACKGROUND OF TYPE 2 DIABETES MELLITUS AND OBESITY.
    Borovyk KM; Kadykova OI; Ryndina NG; Babadzhan VD; Yermak OS
    Wiad Lek; 2023; 76(5 pt 2):1141-1145. PubMed ID: 37364064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Report of the committee on the classification and diagnostic criteria of diabetes mellitus.
    ; Seino Y; Nanjo K; Tajima N; Kadowaki T; Kashiwagi A; Araki E; Ito C; Inagaki N; Iwamoto Y; Kasuga M; Hanafusa T; Haneda M; Ueki K
    J Diabetes Investig; 2010 Oct; 1(5):212-28. PubMed ID: 24843435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of NUCB2/nesfatin-1 in the taste buds of rats.
    Cao X; Zhou X; Cao Y; Liu XM; Zhou LH
    Endocr J; 2016; 63(1):37-45. PubMed ID: 26522144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.
    Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2017 May; 5(5):CD012204. PubMed ID: 28489279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SERUM NESFATIN-1 LEVEL IN HEALTHY SUBJECTS WITH WEIGHT-RELATED ABNORMALITIES AND NEWLY DIAGNOSED PATIENTS WITH TYPE 2 DIABETES MELLITUS; A CASE-CONTROL STUDY.
    Mirakhor Samani S; Ghasemi H; Rezaei Bookani K; Shokouhi B
    Acta Endocrinol (Buchar); 2019; -5(1):69-73. PubMed ID: 31149062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential value of serum Progranulin as a biomarker for the presence and severity of micro vascular complications among Egyptian patients with type 2 diabetes mellitus.
    Albeltagy ES; Hammour AE; Albeltagy SA
    J Diabetes Metab Disord; 2019 Jun; 18(1):217-228. PubMed ID: 31275893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum lutein is a promising biomarker for type 2 diabetes mellitus and diabetic kidney disease in the elderly.
    Pan F; Cui W; Gao L; Shi X; Yang H; Hu Y; Li M
    J Clin Lab Anal; 2022 Apr; 36(4):e24350. PubMed ID: 35293029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Syndrome in Type 2 Diabetes Mellitus Patients: Prevalence, Risk Factors, and Associated Microvascular Complications.
    Asghar S; Asghar S; Shahid S; Fatima M; Bukhari SMH; Nadeem Siddiqui S
    Cureus; 2023 May; 15(5):e39076. PubMed ID: 37323312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum asymmetric dimethylarginine and arginine levels predict microvascular and macrovascular complications in type 2 diabetes mellitus.
    Ganz T; Wainstein J; Gilad S; Limor R; Boaz M; Stern N
    Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27393712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of serum CA199 levels with glycemic control and microvascular complications in patients with type 2 diabetes mellitus.
    Tong W; Gao H; Wei X; Mao D; Zhang L; Chen Q; Zhang Z; Li Y
    Am J Transl Res; 2021; 13(4):3302-3308. PubMed ID: 34017502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation Analysis and Intervention Study on Disturbance of Lipid Metabolism and Diabetic Peripheral Neuropathy.
    Wang W; Li X; Ren Y
    Comput Math Methods Med; 2022; 2022():2579692. PubMed ID: 35242203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Implications of Urinary C-Peptide Creatinine Ratio in Patients with Different Types of Diabetes.
    Wang Y; Gao Y; Cai X; Chen L; Zhou L; Ma Y; Gong S; Han X; Ji L
    J Diabetes Res; 2019; 2019():1747684. PubMed ID: 31485449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predictive value of Thromboelastography (TEG) parameters in vascular complications in patients with type 2 diabetes mellitus.
    Hu B; Zhang L; Zhao ZS; Qi YC; Zhou W; Ma YL
    J Diabetes Complications; 2022 Aug; 36(8):108236. PubMed ID: 35773172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.